Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Senate panel advances bill centralizing state immunization guidance, allows pharmacists to vaccinate ages 7 and up
Loading...
Summary
Senate Finance approved SB 385 (7–3), directing the state health secretary to issue immunization, screening and preventive-service recommendations based on authoritative medical organizations and adding notice-and-comment and MHCC analysis for certain non-immunization preventive recommendations; the bill does not mandate vaccinations and takes effect for plan years starting on or after Jan. 1, 2027.
The Senate Finance Committee voted to advance SB 385, a bill that would require the state health secretary to issue, publish and distribute recommendations for immunizations, screenings and other preventive services that follow generally accepted scientific consensus and sound clinical guidance. The measure, approved 7–3, also permits a pharmacist to administer any vaccination recommended by the secretary to an individual 7 years of age or older.
Sponsor/Presenter said the bill aligns the secretary’s recommendations with “specified authoritative medical organizations” and adds procedural safeguards for certain preventive services: before adopting a non-immunization preventive-service recommendation that lacks a federal precedent, the department must hold a 30‑day notice-and-comment period, obtain a Maryland Health Care Commission (MHCC) analysis and cite the medical authority relied upon. The sponsor also noted the bill adjusts when carriers must cover newly issued recommendations, making coverage apply to plan years that begin one year after the secretary’s recommendations are issued.
Committee members pressed for clarity that the bill would not require individuals to be vaccinated. Chair stated plainly, “this does not require someone to get a vaccine,” a point the sponsor affirmed. Senators asked which federal or medical authorities the department would weigh; the sponsor said the proposal looks to multiple sources — including CDC guidance, FDA approvals, the U.S. Preventive Services Task Force and specialty professional bodies such as the American Academy of Pediatrics and relevant specialty societies — and also to an existing statewide advisory commission on immunizations.
Some members raised concerns about placing named advocacy-oriented medical organizations into law as authoritative sources. The sponsor said the bill does not make any single organization determinative; it instructs the secretary to take multiple authoritative inputs into consideration and to cite the specific medical body that underpins a recommendation.
The committee adopted chair‑offered amendments clarifying the MHCC notice-and-comment requirement and other technical changes. The committee recorded a roll-call vote of 7 in favor and 3 opposed; the chair announced the bill passes. The bill’s effective and coverage timing provisions apply to policies, contracts and health‑benefit plans issued, delivered or renewed on or after Jan. 1, 2027.
The committee’s discussion focused on process and sources of clinical guidance; no citizen testimony was recorded in the session. Next steps: the bill moves from the Finance Committee with the committee’s favorable report and will proceed through the legislative process with the adopted amendments.
